Who Are Anatara Lifesciences Limited’s (ASX:ANR) Major Shareholders?

I am going to take a deep dive into Anatara Lifesciences Limited’s (ASX:ANR) most recent ownership structure, not a frequent subject of discussion among individual investors. Ownership structure of a company has been found to affect share performance over time. Different types of investors can have varying degrees of influence on a company’s management team. For example, an active institutional investor may be more likely to hold a company accountable for certain actions whereas a passive fund will move in and out of stocks without regards to corporate governance. The implications of these institutions’ actions can either benefit or hinder individual investors, so it is important to understand the ownership composition of your stock investment. Now I will analyze ANR’s shareholder registry in more detail.

See our latest analysis for Anatara Lifesciences

ASX:ANR Ownership Summary July 20th 18
ASX:ANR Ownership Summary July 20th 18

Institutional Ownership

Institutional investors typically buy and sell shares in large magnitudes which can significantly sway the share price, especially when there are relatively small amounts of shares available on the market to trade. With an institutional ownership of 5.87%, ANR doesn’t seem too exposed to higher volatility resulting from institutional trading. Apart from low institutional ownership, another indicator of ANR’s low popularity is the fact that the company is only covered by 2 analysts.

Insider Ownership

An important group of shareholders are company insiders. Insider ownership has to do more with how the company is managed and less to do with the direct impact of the magnitude of shares trading on the market. A major group of owners of ANR is individual insiders, sitting with a hefty 20.85% stake in the company. Broadly, insider ownership of this level has been found to negatively affect companies with consistently low PE ratio (underperforming). And a positive impact has been seen on companies with a high PE ratio (outperforming). Another aspect of insider ownership is to learn about their recent transactions. While insider buying is possibly a sign of a positive outlook for the company, selling doesn’t necessarily indicate a negative outlook as they may be selling to meet personal financial needs.

General Public Ownership

A big stake of 49.07% in ANR is held by the general public. This size of ownership gives retail investors collective power in deciding on major policy decisions such as executive compensation, appointment of directors and acquisitions of businesses.

Private Equity Ownership

Private equity firms hold a 6.68% stake in ANR. With a stake of this size, they can be influential in key policy decisions. This is an encouraging sign for investors as these investors tend to be active strategist in companies, focusing on increasing operational and capital efficiency for the firm.

Private Company Ownership

Another important group of owners for potential investors in ANR are private companies that hold a stake of 17.13% in ANR. These are companies that are mainly invested due to their strategic interests or are incentivized by reaping capital gains on investments their shareholdings. An ownership of this size indicates a strong financial backing and has the potential to influence ANR’s business strategy. Thus, investors should dig deeper into ANR’s business relations with these companies and how it can affect shareholder returns in the long-term.

Next Steps:

Institutional ownership in ANR is not at a level that would concern investors. We are less likely to see sustained downtrends or significant volatility resulting from large institutional trading. However, ownership structure should not be the only determining factor when you’re building an investment thesis for ANR. Rather, you should be looking at fundamental drivers such as Anatara Lifesciences’s past track record and financial health. I urge you to complete your research by taking a look at the following:

  1. Future Outlook: What are well-informed industry analysts predicting for ANR’s future growth? Take a look at our free research report of analyst consensus for ANR’s outlook.
  2. Past Track Record: Has ANR been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of ANR’s historicals for more clarity.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.